Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines
ChemBioChem · 14.04.2026 · 27 (7)
DOI: 10.1002/cbic.202500894 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 14.04.2026. Verfasst von Yongqing Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical, Pharmaceutical Co Ltd., Shijiazhuang, China. Hauptthemen laut MEDLINE: Dihydropyridines. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
The 1,4‐dihydropyridine (1,4‐DHP) scaffold is a privileged scaffold in numerous therapeutic agents, including L‐type calcium channel blockers, mineralocorticoid receptor antagonists, and calcitonin gene‐related peptide receptor antagonists. The chirality at the C4 position of the 1,4‐DHP core critically influences its pharmacological activity. Recent advances in asymmetric synthesis, particularly through organocatalysis and transition metal catalysis, have enabled efficient and stereoselective routes to access enantiomerically enriched 1,4‐DHP derivatives. However, a comprehensive review summarizing these asymmetric synthetic strategies for this pivotal scaffold is still lacking. This article systematically summarizes recent progress in the asymmetric synthesis of 1,4‐DHPs, focusing on catalytic systems involving organocatalysts and transition metal complexes. It further highlights their significant potential in constructing key chiral intermediates for pharmaceutical development, aiming to provide novel perspectives for the research and development of chiral 1,4‐DHP‐based drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical, Pharmaceutical Co Ltd., Shijiazhuang, China.
- Hebei Guangxiang Pharmaceutical Co Ltd., Cangzhou, China.
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Organic Chemistry, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Jie Feng
Zitieren
APA
Ma, Y., Huang, Y., Yan, Y., Shi, H., Cui, Y., Yang, J., Ren, K., & Feng, J. (2026). Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines. ChemBioChem, 27(7). https://doi.org/10.1002/cbic.202500894
Vancouver
Ma Y, Huang Y, Yan Y, Shi H, Cui Y, Yang J, et al. Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines. ChemBioChem. 2026;27(7). doi:10.1002/cbic.202500894
BibTeX
@article{Ma2026,
author = {Ma, Yongqing and Huang, Yifeng and Yan, Yuxuan and Shi, Hongchao and Cui, Yongbin and Yang, Junmian and Ren, Kuo and Feng, Jie},
title = {Recent Advances in Asymmetric Synthesis of 1,4‐Dihydropyridines},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {7},
doi = {10.1002/cbic.202500894}
}
EUVIMED